Literature DB >> 25198981

A cross-specialty survey to assess the application of risk stratified surgery for differentiated thyroid cancer in the UK.

W L Craig1, C R Ramsay, S Fielding, Z H Krukowski.   

Abstract

INTRODUCTION: This study describes variability of treatment for differentiated thyroid cancer among thyroid surgeons, in the context of changing patterns of thyroid surgery in the UK.
METHODS: Hospital Episodes Statistics on thyroid operations between 1997 and 2012 were obtained for England. A survey comprising six scenarios of varying 'risk' was developed. Patient/tumour information was provided, with five risk stratified or non-risk stratified treatment options. The survey was distributed to UK surgical associations. Respondent demographics were categorised and responses analysed by assigned risk stratified preference.
RESULTS: From 1997 to 2012, the Hospital Episode Statistics data indicated there was a 55% increase in the annual number of thyroidectomies with a fivefold increase in otolaryngology procedures and a tripling of cancer operations. Of the surgical association members surveyed, 264 respondents reported a thyroid surgery practice. Management varied across and within the six scenarios, and was not related consistently to the level of risk. Associations were demonstrated between overall risk stratified preference and higher volume practice (>25 thyroidectomies per year) (p=0.011), fewer years of consultant practice (p=0.017) and multidisciplinary team participation (p=0.037). Logistic regression revealed fewer years of consultant practice (odds ratio [OR]: 0.96/year in practice, 95% confidence interval [CI]: 0.922-0.997, p=0.036) and caseload of >25/year (OR 1.92, 95% CI: 1.044-3.522, p=0.036) as independent predictors of risk stratified preference.
CONCLUSIONS: There is a substantial contribution to thyroid surgery in the UK by otolaryngology surgeons. Adjusting management according to established case-based risk stratification is not widely applied. Higher caseload was associated with a preference for management tailored to individual risk.

Entities:  

Mesh:

Year:  2014        PMID: 25198981      PMCID: PMC4474201          DOI: 10.1308/003588414X13946184902884

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  34 in total

1.  Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications.

Authors:  Arja Jukkola; Risto Bloigu; Tapani Ebeling; Pasi Salmela; Guillermo Blanco
Journal:  Endocr Relat Cancer       Date:  2004-09       Impact factor: 5.678

Review 2.  A systematic review of the impact of volume of surgery and specialization on patient outcome.

Authors:  M M Chowdhury; H Dagash; A Pierro
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

3.  Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours.

Authors:  Juan P Brito; John C Morris; Victor M Montori
Journal:  BMJ       Date:  2013-08-27

4.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  Risk factors for medically treated hypocalcemia after surgery for Graves' disease: a Swedish multicenter study of 1,157 patients.

Authors:  P Hallgrimsson; E Nordenström; M Almquist; A O J Bergenfelz
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

6.  Low-risk differentiated thyroid cancer: the need for selective treatment.

Authors:  A R Shaha; J P Shah; T R Loree
Journal:  Ann Surg Oncol       Date:  1997-06       Impact factor: 5.344

Review 7.  Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.

Authors:  Davide Giordano; Roberto Valcavi; Geoffrey B Thompson; Corrado Pedroni; Luigi Renna; Paolo Gradoni; Verter Barbieri
Journal:  Thyroid       Date:  2012-07-24       Impact factor: 6.568

8.  Central compartment dissection in thyroid papillary carcinoma.

Authors:  Veronique-Isabelle Forest; Jonathan R Clark; Ardalan Ebrahimi; Eun-Ae Cho; Lorna Sneddon; Kan Gao; Chris J O'brien
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

9.  Reoperative surgery for thyroid disease.

Authors:  Jérémie H Lefevre; Christophe Tresallet; Laurence Leenhardt; Christelle Jublanc; Jean-Paul Chigot; Fabrice Menegaux
Journal:  Langenbecks Arch Surg       Date:  2007-06-26       Impact factor: 3.445

10.  Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients.

Authors:  Paolo Goffredo; Kevin Cheung; Sanziana A Roman; Julie A Sosa
Journal:  Ann Surg Oncol       Date:  2012-10-31       Impact factor: 5.344

View more
  1 in total

1.  Learning Curve for Transoral Endoscopic Thyroid Lobectomy.

Authors:  Christopher R Razavi; Elya Vasiliou; Ralph P Tufano; Jonathon O Russell
Journal:  Otolaryngol Head Neck Surg       Date:  2018-08-21       Impact factor: 3.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.